Glutathione
Half-Life (t½) PO: 10m · IV: 10m
Formula C10H17N3O6S
Molecular Weight 307.32 g/mol
Aliases GSH, reduced glutathione, γ-glutamylcysteinylglycine Pharmacological Mechanism γ-Glu-Cys-Gly tripeptide synthesized by γ-GCS (rate-limiting) and GS. Donates electrons via cysteine thiol in GPX-catalyzed peroxide reduction, oxidizing to GSSG; regenerated by GR using NADPH. Central cofactor for phase-II conjugation (GSTs), electrophile detox, and maintaining protein thiol redox state. Oral free GSH is largely hydrolyzed; NAC is the preferred cysteine delivery precursor for raising intracellular GSH.
Half-Life & Elimination Curve (PO: 10m · IV: 10m) 100% 50% 25% 12.5% 0% 0h 0×t½ 10m 1×t½ 20m 2×t½ 31m 3×t½ 41m 4×t½ 51m 5×t½ 0×t½ (0h): 100% remaining (~0.762 mg/L) 1×t½ (10m): 50% remaining (~0.381 mg/L) 2×t½ (20m): 25% remaining (~0.191 mg/L) 3×t½ (31m): 12.5% remaining (~95.3 µg/L) 4×t½ (41m): 6.3% remaining (~47.6 µg/L) 5×t½ (51m): 3.1% remaining (~23.8 µg/L) Elimination (PO)
0×t½ 0h 100% (0.762 mg/L) 1×t½ 10m 50% (0.381 mg/L) 2×t½ 20m 25% (0.191 mg/L) 3×t½ 31m 12.5% (95.3 µg/L) 4×t½ 41m 6.3% (47.6 µg/L) 5×t½ 51m 3.1% (23.8 µg/L) Dosing Guidelines Oral (PO): Typical 667 mg (Range: 500–1000 mg)Intravenous (IV): Typical 667 mg (Range: 500–1000 mg)Inhaled (INH): Typical 667 mg (Range: 500–1000 mg)Pharmacokinetic Parameters Oral (PO): Bioavailability (F): 2% · Volume of Distribution (Vd): 17.5 L [PMID 1907548 ]Intravenous (IV): Bioavailability (F): 100% · Volume of Distribution (Vd): 17.5 L [PMID 1907548 ]Pathways It Modulates Target Organ Systems Chemical Structure & Identifiers InChIKey: RWSXRVCMGQZWBV-WDSKDSINSA-NSMILES: C(CC(=O)N[C@@H](CS)C(=O)NCC(=O)O)[C@@H](C(=O)O)NRecon3D Metabolite ID: gthrdReferences Directory Compounds Registry Human Biology Hub